Breann Owen, FNP-C in Amenia, ND - Nurse Practitioner

Breann Owen, FNP-C is a Nurse Practitioner - Family based in Amenia, North Dakota. Breann Owen is licensed to practice in North Dakota (license number R33266) and her current practice location is 14974 27th St Se, Amenia, North Dakota. She can be reached at her office (for appointments etc.) via phone at (701) 840-2047.

NPI number for Breann Owen is 1811505241 and her current mailing address is 14974 27th St Se, Amenia, North Dakota. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1811505241.

Contact Information

	Breann Owen, FNP-C
	14974 27th St Se, Amenia, ND 58004-9756
	(701) 840-2047
	Not Available

Provider's Profile

Full Name	Breann Owen
Gender	Female
Speciality	Nurse Practitioner - Family
Location	14974 27th St Se, Amenia, North Dakota
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1811505241
Provider Enumeration Date: 07/22/2020
Last Update Date: 07/22/2020

Medical Identifiers

Medical identifiers for Breann Owen such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1811505241	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
363LF0000X	Nurse Practitioner - Family	R33266 (North Dakota)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Breann Owen is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Breann Owen, FNP-C 14974 27th St Se, Amenia, ND 58004-9756 Ph: (701) 840-2047	Breann Owen, FNP-C 14974 27th St Se, Amenia, ND 58004-9756 Ph: (701) 840-2047

News Archive

New cancer drug shows promise to treat leukemia in mouse models

Almost 6,000 new cases of acute lymphoblastic leukemia, or ALL, are expected to be diagnosed this year in the United States. The blood cancer can affect both children and adults.

New insights into immune exhaustion

A main reason why viruses such as HIV or hepatitis C persist despite a vigorous initial immune response is exhaustion. The T cells, or white blood cells, fighting a chronic infection eventually wear out.

PureTech Health collaborates with Roche to advance oral administration of antisense oligonucleotides

PureTech Health plc, a clinical-stage biopharmaceutical company developing novel medicines focused on the Brain-Immune-Gut Axis, today announced that it has entered into a multiyear collaboration with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., to advance PureTech's milk-derived exosome platform technology for the oral administration of Roche's antisense oligonucleotide platform.

Scientists discover how polyphenols present in red wine and green tea inhibit prostate cancer growth

In what could lead to a major advance in the treatment of prostate cancer, scientists now know exactly why polyphenols in red wine and green tea inhibit cancer growth. This new discovery, published online in The FASEB Journal, explains how antioxidants in red wine and green tea produce a combined effect to disrupt an important cell signaling pathway necessary for prostate cancer growth.

BRAF inhibitors may be effective at treating rare ovarian cancer, study shows

New research has shown that ovarian cancer patients with a tumor mutation in the BRAF gene respond exceptionally well to treatment with targeted drugs, known as BRAF inhibitors.

Breann Owen, FNP-C - Nurse Practitioner in Amenia, ND